Noticias de Eulerpool Gensight Biologics

Gensight Biologics Noticias de Acciones

Gensight Biologics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Gensight Biologics.

• 12 de junio ·

  Yahoo
  GenSight Biologics Reaches Agreement with ANSM for Opening of LUMEVOQ® Named Early Access Program (AAC) in France
• 13 de mayo ·

  Yahoo
  GenSight Biologics Announces Approval of All Resolutions Supported by the Board of Directors at the Combined General Meeting of May 13, 2025
• 8 de abril ·

  Yahoo
  GenSight Biologics Announces the Filing of its 2024 Universal Registration Document
• 7 de abril ·

  Yahoo
  GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update
• 12 de febrero ·

  Yahoo
  GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
• 13 de noviembre ·

  Yahoo
  GenSight Biologics Announces Submission of LUMEVOQ® Dossier to ANSM to Prepare for Restart of Early Access Program in France
• 28 de octubre ·

  Yahoo
  GenSight Biologics Announces Publication of Meta-Analyses Showing Better Outcomes for ND4-LHON Patients Treated with LUMEVOQ®
• 24 de octubre ·

  Yahoo
  GenSight Biologics Reports Cash Position as of September 30, 2024, and Provides Business Update
• 17 de octubre ·

  Yahoo
  GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024
• 23 de septiembre ·

  Yahoo
  GenSight Biologics Reports Interim Financial Results for the First Half of 2024, Provides Business Updates